Enalare Therapeutics Inc.

Name: Enalare Therapeutics Inc.
Address: 161 Hodge Rd, Princeton, New Jersey, United States, 08540-3013, Princeton
Telephone: '+1 609-325-7701

Princetonpharmaceuticals

About

Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey. Founded between 2018 and 2020, the company focuses on developing innovative therapies for life-threatening acute respiratory and critical care conditions. Their lead product, ENA-001, is a novel respiratory stimulant currently in clinical trials, designed to address issues such as drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare is committed to rapid development of first-in-class compounds and has demonstrated safety and efficacy in multiple human studies. The company holds a strong intellectual property portfolio, including patents that extend into the 2030s. They have secured significant funding and partnerships, including collaborations with BARDA and NIH/NIDA, to advance their research and development efforts. Enalare aims to meet critical healthcare needs in various settings, including community and hospital environments.